AZO
- Manufacturer
- i-Health, Inc.
- Effective date
- 2026-01-05
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 8
- Source
- full-release
- Hydrated at
- 2026-06-01 01:31:13
Label at a glance#
Contacts and useful links#
Label contents#
Full prescribing information#
Drug Facts
Active ingredient (in each tablet)
Phenazopyridine Hydrochloride 95 mg
OTC - PURPOSE SECTION
Purpose
Urinary analgesic
INDICATIONS & USAGE SECTION
UseRelief from urinary pain, burning, urgency and frequency associated with urinary tract infections.
WARNINGS SECTION
Warnings Please read insert for important precautions.
Ask a doctor before use if you have
- kidney disease
- allergies to foods, preservatives or dyes
- had a hypersensitive reaction to Phenazopyridine Hydrochloride.
OTC - DO NOT USE SECTION
Caution:Do not use this product if you have Glucose-6-Phosphate Dehydrogenase (G6PD) deficiency unless approved by your physician.
OTC - WHEN USING SECTION
When using this product
- stomach upset may occur, taking this product with or after meals may reduce stomach upset.
- your urine will become reddish-orange in color. This is not harmful, but care should be taken to avoid staining clothing or other items.
OTC - STOP USE SECTION
Stop use and ask doctor
- your symptoms last for more than 2 days
- you suspect you are having an adverse reaction to the medication.
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
Keep out of reach of children. In case of an overdose, get medical help or contact a Poison Control Center right away.
DOSAGE & ADMINISTRATION SECTION
Directions
- Adults and children 12 years or older: Take 2 tablets 3 times daily with or after meals as needed for up to two days. Take with a full glass of water. Do not use for more than 2 days (12 tablets) without consulting a doctor.
- Children under 12: Do not use without consulting a doctor.
GENERAL PRECAUTIONS SECTION
Other Inf ormation
- This product can interfere with laboratory tests including urine, glucose (sugar), and ketones tests
- This product may stain soft contact lenses and other items if handled after touching tablets
- Store at room temperature (59-86 F) in a dry place and protect from light
- Tamper evident: tablets sealed in blisters. Do not use if blister foil or seal is open or damaged.
INACTIVE INGREDIENT SECTION
Inactive ingredientsmicrocrystalline cellulose, pregelatinized corn starch, hypromellose, povidine, croscarmellose sodium, polyethylene glycol, carnauba wax and vegetable magnesium stearate. May also contain corn starch.
OTC - QUESTIONS SECTION
Distributed by i-Health, Inc.
25 Bacon Road, Enfield, CT 06082
Made in India.
Most Trusted Brand based on Nielsen data through 3/23/2013.
For questions, concerns, or to report an adverse event, call (800) 722-3476
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
AZO
Urinary Pain Relief
- Relieves pain, burning & urgency
- Targets the source of pain
#1 Most Trusted Brand
Tablets
95 mg Phenazopyridine Hydrochloride
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | SPL version |
|---|---|---|---|
| 1094192 | Azo Urinary Pain Relief 95 MG Oral Tablet | PSN | 8 |
| 1094126 | phenazopyridine HCl 95 MG Oral Tablet | PSN | 8 |
| 1094192 | phenazopyridine hydrochloride 95 MG Oral Tablet [Azo Urinary Pain Relief] | SBD | 8 |
| 1094126 | phenazopyridine hydrochloride 95 MG Oral Tablet | SCD | 8 |
| 1094192 | Azo Urinary Pain Relief 95 MG Oral Tablet | SY | 8 |
| 1094126 | phenazopyridine HCl 95 MG Oral Tablet | SY | 8 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 49973-301-30 | AZO | 15 in 1 BOX | TABLET | 15 | 8 | |
| 49973-301-30 | AZO | 2 in 1 BLISTER PACK | TABLET | 2 | 8 | |
| 49973-301-31 | AZO | 15 in 1 BOX | TABLET | 15 | 8 | |
| 49973-301-31 | AZO | 2 in 1 BLISTER PACK | TABLET | 2 | 8 | |
| 49973-301-32 | AZO | 1 in 1 BOX | TABLET | 1 | 8 | |
| 49973-301-32 | AZO | 18 in 1 BLISTER PACK | TABLET | 18 | 8 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 49973-301-31 | EA - Each | 49973-301 | 188f7be8-bc47-4830-b185-86c345159e86 | 1 | 2019-12-10 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| Phenazopyridine Hydrochloride | ACTIVE INGREDIENT | 0EWG668W17 | 3 | |
| Phenazopyridine | ACTIVE MOIETY | K2J09EMJ52 | 3 | |
| CARNAUBA WAX | INACTIVE INGREDIENT | R12CBM0EIZ | 3 | |
| CELLULOSE, MICROCRYSTALLINE | INACTIVE INGREDIENT | OP1R32D61U | 3 | |
| CROSCARMELLOSE SODIUM | INACTIVE INGREDIENT | M28OL1HH48 | 3 | |
| HYPROMELLOSES | INACTIVE INGREDIENT | 3NXW29V3WO | 3 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | 3 | |
| POLYETHYLENE GLYCOLS | INACTIVE INGREDIENT | 3WJQ0SDW1A | 3 | |
| POVIDONE | INACTIVE INGREDIENT | FZ989GH94E | 3 | |
| STARCH, CORN | INACTIVE INGREDIENT | O8232NY3SJ | 3 |
Products#
Every source-derived product name is available through these pages.
- AZO
- Urinary Pain Relief
- CELLULOSE, MICROCRYSTALLINE
- STARCH, CORN
- HYPROMELLOSES
- POVIDONE, UNSPECIFIED
- CROSCARMELLOSE SODIUM
- POLYETHYLENE GLYCOL, UNSPECIFIED
- CARNAUBA WAX
- MAGNESIUM STEARATE
- PHENAZOPYRIDINE HYDROCHLORIDE
- PHENAZOPYRIDINE
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 49973-301 | 49973-301-31, 49973-301-30, 49973-301-32 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| CELLULOSE, MICROCRYSTALLINE | OP1R32D61U | IACT |
| STARCH, CORN | O8232NY3SJ | IACT |
| HYPROMELLOSES | 3NXW29V3WO | IACT |
| POVIDONE, UNSPECIFIED | FZ989GH94E | IACT |
| CROSCARMELLOSE SODIUM | M28OL1HH48 | IACT |
| POLYETHYLENE GLYCOL, UNSPECIFIED | 3WJQ0SDW1A | IACT |
| CARNAUBA WAX | R12CBM0EIZ | IACT |
| MAGNESIUM STEARATE | 70097M6I30 | IACT |
| PHENAZOPYRIDINE HYDROCHLORIDE | 0EWG668W17 | ACTIB |
Source Document#
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| STARCH, CORN | STARCH, CORN | O8232NY3SJ | TABLET / ORAL | 1116 mg | ||
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | TABLET / ORAL | 1127 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | TABLET / ORAL | 980 mg | ||
| STARCH, CORN | STARCH, CORN | O8232NY3SJ | TABLET / ORAL | 1116 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | TABLET / ORAL | 980 mg | ||
| CROSCARMELLOSE SODIUM | CROSCARMELLOSE SODIUM | M28OL1HH48 | TABLET / ORAL | 736 mg | ||
| POVIDONE | POVIDONE | FZ989GH94E | TABLET / ORAL | 216 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | TABLET / ORAL | 980 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET / ORAL | 6184 mg | ||
| POVIDONE | POVIDONE | FZ989GH94E | TABLET / ORAL | 216 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET / ORAL | 6184 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | TABLET / ORAL | 980 mg | ||
| STARCH, CORN | STARCH, CORN | O8232NY3SJ | TABLET / ORAL | 1116 mg | ||
| CROSCARMELLOSE SODIUM | CROSCARMELLOSE SODIUM | M28OL1HH48 | TABLET / ORAL | 736 mg | ||
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | TABLET / ORAL | 1127 mg | ||
| POVIDONE | POVIDONE | FZ989GH94E | TABLET / ORAL | 216 mg | ||
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | TABLET / ORAL | 1127 mg | ||
| CARNAUBA WAX | CARNAUBA WAX | R12CBM0EIZ | TABLET / ORAL | 167.8 mg | ||
| CARNAUBA WAX | CARNAUBA WAX | R12CBM0EIZ | TABLET / ORAL | 167.8 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET / ORAL | 6184 mg | ||
| CARNAUBA WAX | CARNAUBA WAX | R12CBM0EIZ | TABLET / ORAL | 167.8 mg | ||
| POVIDONE | POVIDONE | FZ989GH94E | TABLET / ORAL | 216 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET / ORAL | 6184 mg | ||
| CROSCARMELLOSE SODIUM | CROSCARMELLOSE SODIUM | M28OL1HH48 | TABLET / ORAL | 736 mg | ||
| STARCH, CORN | STARCH, CORN | O8232NY3SJ | TABLET / ORAL | 1116 mg | ||
| CROSCARMELLOSE SODIUM | CROSCARMELLOSE SODIUM | M28OL1HH48 | TABLET / ORAL | 736 mg | ||
| CARNAUBA WAX | CARNAUBA WAX | R12CBM0EIZ | TABLET / ORAL | 167.8 mg | ||
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | TABLET / ORAL | 1127 mg |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| AZO | URINARY PAIN RELIEF | i-Health, Inc. | 3d0298b7-eaec-488b-9cab-19af4614ff53 | 2026-01-05 | Warnings | 49973-301-32 49973-301-30 49973-301-31 49973-301 49973030131 49973030132 49973030130 47a4fa0f-9c93-6286-e063-6394a90aa070 3d0298b7-eaec-488b-9cab-19af4614ff53 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.

